Betamethasone / Calcipotriene Topical Dosage
Medically reviewed by Drugs.com. Last updated on Apr 6, 2021.
Applies to the following strengths: 0.064%-0.005%
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Psoriasis
OINTMENT:
-Apply to the affected area(s) once a day for up to 4 weeks; rub in gently and completely
-The maximum weekly dose should not exceed 100 g.
-Treatment of more than 30% body surface area is not recommended.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
TOPICAL SUSPENSION:
-Apply to affected area(s) once daily for up to 8 weeks.
-The maximum weekly dose should not exceed 100 g.
-Treatment of more than 30% body surface area is not recommended.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
FOAM AEROSOL:
-Apply to affected area(s) once daily for up to 4 weeks; rub in gently and completely
-Do not use more than 60 g every 4 days.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
Uses:
-Ointment formulation: For the topical treatment of plaque psoriasis in patients 12 years of age and older
-Topical suspension: For plaque psoriasis of the scalp and body in patients 18 years and older
-Foam aerosol: For the topical treatment of plaque psoriasis in patients 18 years of age and older
Usual Pediatric Dose for Psoriasis
OINTMENT:
12 years and older:
-Apply to the affected area(s) once a day for up to 4 weeks; rub in gently and completely
-The maximum weekly dose should not exceed 60 g.
-Treatment of more than 30% body surface area is not recommended.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
TOPICAL SUSPENSION:
12 years and older:
-Apply to affected area(s) once daily for up to 8 weeks.
-The maximum weekly dose should not exceed 60 g.
-Treatment of more than 30% body surface area is not recommended.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
FOAM AEROSOL:
12 years and older:
-Apply to affected area(s) once daily for up to 4 weeks; rub in gently and completely
-Do not use more than 60 g every 4 days.
-Discontinue therapy when control is achieved.
-Do not use with occlusive dressings unless directed by a physician.
-Avoid use on the face, eyes, groin, or axillae, or if skin atrophy is present at the treatment site.
Uses:
-Ointment and foam formulations: For the topical treatment of plaque psoriasis in patients 12 years of age and older
-Topical suspension: For plaque psoriasis of the scalp in patients 12 to 17 years
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
CONTRAINDICATIONS:
-None
Safety and efficacy have not been established in patients younger than 12 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
-Rub product in gently and completely.
-Patients should wash their hands after application of the product.
-Avoid excessive exposure to either natural or artificial sunlight. Physicians may wish to limit or avoid use of phototherapy in such patients.
-Do not use this drug combination orally, ophthalmically, or intravaginally.
-Instruct patients to shake bottle prior to using the topical suspension or foam.
General:
This topical drug combination may cause eye irritation. Eye exposure should be avoided.
More about betamethasone / calcipotriene topical
- Side effects
- Drug interactions
- During pregnancy
- Reviews (114)
- Pricing & coupons
- En español
- Drug class: topical antipsoriatics
Patient resources
- Drug Information
- Betamethasone and calcipotriene Topical application (Advanced Reading)
- Calcipotriene and Betamethasone Foam
- Calcipotriene and Betamethasone Gel and Topical Suspension
- Calcipotriene and Betamethasone Ointment
- Other brands
- Enstilar, Taclonex, Wynzora, Taclonex Scalp
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.